GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NovMetaPharma Co Ltd (XKRX:229500) » Definitions » 5-Year Yield-on-Cost %

NovMetaPharma Co (XKRX:229500) 5-Year Yield-on-Cost % : 0.00 (As of May. 04, 2025)


View and export this data going back to 2015. Start your Free Trial

What is NovMetaPharma Co 5-Year Yield-on-Cost %?

NovMetaPharma Co's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for NovMetaPharma Co's 5-Year Yield-on-Cost % or its related term are showing as below:



XKRX:229500's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.22
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of NovMetaPharma Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, NovMetaPharma Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NovMetaPharma Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NovMetaPharma Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where NovMetaPharma Co's 5-Year Yield-on-Cost % falls into.


;
;

NovMetaPharma Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of NovMetaPharma Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

NovMetaPharma Co  (XKRX:229500) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


NovMetaPharma Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of NovMetaPharma Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


NovMetaPharma Co Business Description

Traded in Other Exchanges
N/A
Address
727 13, Gangnam-gu, Seoul eonju layer, Seoul, KOR
NovMetaPharma Co Ltd researches and develops new medicines and health supplements for metabolic diseases. The company is developing a therapeutic agent that is in Phase 2a clinical trial for Type 2 diabetes and obesity. It also develops therapeutic agents for Alzheimer's disease, immune system diseases, osteoporosis, and non-alcoholic fatty liver diseases.

NovMetaPharma Co Headlines

No Headlines